News Focus
News Focus
Followers 269
Posts 18913
Boards Moderated 0
Alias Born 01/19/2006

Re: JRoon71 post# 432492

Thursday, 01/23/2025 11:54:01 AM

Thursday, January 23, 2025 11:54:01 AM

Post# of 447903
Amarin shares trading at $0.59- 0.60, values we have not seen for quite some time. Potential tariffs on generic products made/manufactured abroad may be a factor. Customs holding such products at port entry, preventing distribution and sale elsewhere in the country may be another. CNN reported a few hours ago that the Attorney General nominee from Florida has opposed generic products that cause elevated drug prices in the United States. I have a bottle of one such generic product that cost me far more than the $9-$15 co-pay I used to pay for a 3-month refill of Brand Vascepa prior to 7/01/2024. Remember the recent CAFC observation that the Hikma product has not been FDA-approved for CVD indications, nor was there record evidence that such product was a therapeutic 
equivalent of Amarin's brand Vascepa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News